Plus Therapeutics, Inc. (PSTV)
NASDAQ·Healthcare·Biotechnology
$3.61
-4.12%
Mkt Cap $14.49M
Analyst Ratings
Buy
2
Hold
1
Sell
0
Price Target (2 analysts)
$25.00
Range $25.00 – $25.00
Implied Upside
+593.5%
Consensus $25.00 vs current $3.61
NASDAQ·Healthcare·Biotechnology
$3.61
-4.12%
Mkt Cap $14.49M
Buy
2
Hold
1
Sell
0
Price Target (2 analysts)
$25.00
Range $25.00 – $25.00
+593.5%
Consensus $25.00 vs current $3.61